Wexford Capital’s Bio-Techne TECH Stock Holding History

Wexford Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,400	Closed	-$364K	–	187
2017 Q2	$364K	Buy	+12,400	New	+$339K	0.03%	128

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wexford Capital's TECH Position: Q3 2017 in Review

Wexford Capital sold out of Bio-Techne (TECH) in Q3 2017, closing a stake of 12,400 shares — an estimated $364K sold.

Wexford Capital first reported a position in TECH in Q2 2017 and held it in 1 quarter. The position peaked at $364K in Q2 2017. 292 funds tracked by Wall St. Rank hold TECH as of Q3 2017.

Wexford Capital reported no remaining Bio-Techne position as of Q3 2017 after selling out during the quarter.
Wexford Capital sold 12,400 Bio-Techne shares in Q3 2017, an estimated $364K.
Wexford Capital first reported a position in Bio-Techne in Q2 2017 and held it in 1 quarter.
Wexford Capital's Bio-Techne position peaked at $364K in Q2 2017.
292 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2017.

Based on Wexford Capital's 13F filing for Q3 2017, filed 13 Nov 2017.